TrianglePUBLICATIONS · 37751561
Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket Study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2023 Dec 20
- First author
- Nakamura Y
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Nakamura Y
- type
- Author
- name
- Mizuno N
- type
- Author
- name
- Sunakawa Y
- type
- Author
- name
- Canon JL
- type
- Author
- name
- Galsky MD
- type
- Author
- name
- Hamilton E
- type
- Author
- name
- Hayashi H
- type
- Author
- name
- Jerusalem G
- type
- Author
- name
- Kim ST
- type
- Author
- name
- Lee KW
- type
- Author
- name
- Kankeu Fonkoua LA
- type
- Author
- name
- Monk BJ
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Nakamura Y
- type
- Author
- name
- Mizuno N
- type
- Author
- name
- Sunakawa Y
- type
- Author
- name
- Canon JL
- type
- Author
- name
- Galsky MD
- type
- Author
- name
- Hamilton E
- type
- Author
- name
- Hayashi H
- type
- Author
- name
- Jerusalem G
- type
- Author
- name
- Kim ST
- type
- Author
- name
- Lee KW
- type
- Author
- name
- Kankeu Fonkoua LA
- type
- Author
- name
- Monk BJ
- type
- Author
- bibliography ids
- nci-bib-ff0afa90b43d04ae02527435
- book metadata
- content sha256
- f5e9505ebcc619217ebd4b514a31dfc09d81593da980474c893ab2fb733f559d
- document type
- citation
- dois
- 10.1200/JCO.23.00606
- electronic publication date
- display
- 2023 Sep 26
- precision
- day
- year
- 2023
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:37751561
- immutable id
- pubmed:37751561@f5e9505ebcc619217ebd4b514a31dfc09d81593da980474c893ab2fb733f559d
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 36
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 5569-5578
- volume
- 41
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 37751561
- provenance
- batch id
- 5329a5d0877ee70ecd11
- provider
- NCBI PubMed ESummary
- record sha256
- 09b40c1bca8e31c08d4966f984b645149d39a5824d6bb714149355968769e6f2
- response sha256
- bcc4d4935bae07b2d0bf7ef24187cf1ff9d849601f315c9dbe2002bd5de6f631
- retrieved at
- 2026-09-09T23:48:15.763286+00:00
- publication date
- display
- 2023 Dec 20
- precision
- day
- year
- 2023
- publication types
- Clinical Trial, Phase II
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket Study.
Preserved source evidence · Not medical advice